Stay updated on NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial
Sign up to get notified when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.

Latest updates to the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page
- ChecktodayChange DetectedThe web page has been updated to include a new facility name and location, along with a list of publications related to a clinical trial, while removing specific location details and drug information.SummaryDifference5%
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check30 days agoChange DetectedThe web page has been updated to a new version (v2.16.10), and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
- Check37 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
Stay in the know with updates to NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.